SANOFI.NS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 May 2024 @ 06:00):

Stats
Today's Volume	31 763.00
Average Volume	18 789.00
Market Cap	198.62B
EPS	INR0 ( 2024-02-23 )
Next earnings date	( INR0 ) 2024-05-10
Last Dividend	INR183.00 ( 2023-04-28 )
Next Dividend	INR0 ( N/A )
P/E	32.91
ATR14	INR9.44 (0.11%)

Volume Correlation

Long: 0.53 (weak)

Short: 0.73 (moderate)

Signal:(50.933) Neutral

Sanofi India Limited Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Sanofi India Limited Correlation - Currency/Commodity

-0.59
( weak negative )

-0.35
( neutral )

0.09
( neutral )

-0.56
( weak negative )

-0.55
( weak negative )

0.77
( moderate )

Sanofi India Limited Financials

Annual	2023
Revenue:	INR28.51B
Gross Profit:	INR12.40B (43.49 %)
EPS:	INR261.78

FY	2023
Revenue:	INR28.51B
Gross Profit:	INR12.40B (43.49 %)
EPS:	INR261.78

FY	2022
Revenue:	INR27.70B
Gross Profit:	INR15.81B (57.06 %)
EPS:	INR269.47

FY	2021
Revenue:	INR29.57B
Gross Profit:	INR16.50B (55.80 %)
EPS:	INR410.06

Financial Reports:

No articles found.

Sanofi India Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR193.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR183.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Sanofi India Limited Dividend Information - Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 2.07 - Decrease likely (58.50%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR13.50	2003-05-30
Last Dividend	INR183.00	2023-04-28
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	39	--
Total Paid Out	INR1 983.50	--
Avg. Dividend % Per Year	2.98%	--
Score	4.06	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	2.07
Div. Directional Score	6.59	--

Next Divdend (Est)
(2024-10-07)

INR189.96 Estimate 3.64 %

Dividend Stability

0.29 Very Poor

Dividend Score

4.06

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2003	INR0	0.00%
2004	INR0	0.00%
2005	INR0	0.00%
2006	INR0	0.00%
2007	INR0	0.00%
2008	INR0	0.00%
2009	INR0	0.00%
2010	INR0	0.00%
2011	INR0	0.00%
2012	INR0	0.00%
2013	INR0	0.00%
2014	INR0	0.00%
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR71.00	1.47%
2019	INR66.00	1.04%
2020	INR486.00	6.93%
2021	INR240.00	2.90%
2022	INR502.00	6.45%
2023	INR183.00	3.14%
2024	INR0	0.00%

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SKFINDIA.NS	Dividend Junior	2023-06-28	Annually	22	0.93%
METROBRAND.NS	Dividend Junior	2023-08-31	Semi-Annually	3	0.18%
HAL.NS	Dividend Knight	2023-08-24	Semi-Annually	6	4.33%
BCG.NS	Ex Dividend Junior	2023-09-28	Sporadic	9	0.20%
PSB.NS	No Dividend Player	2023-07-04	Sporadic	14	0.77%
KCP.NS	Dividend Junior	2023-08-10	Annually	23	0.55%
EIMCOELECO.NS	Dividend Knight	2023-06-16	Annually	23	0.80%
AGARIND.NS	Ex Dividend Junior	2023-09-08	Annually	11	0.44%
SUMICHEM.NS	Dividend Junior	2023-07-20	Annually	5	0.17%
NATCOPHARM.NS	Dividend Junior	2023-08-22	Semi-Annually	29	0.68%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.211	1.500	5.77	8.66	[0 - 0.5]
returnOnAssetsTTM	0.352	1.200	10.00	10.00	[0 - 0.3]
returnOnEquityTTM	0.645	1.500	3.95	5.92	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	1.916	0.800	5.42	4.34	[1 - 3]
quickRatioTTM	0.860	0.800	9.65	7.72	[0.8 - 2.5]
cashRatioTTM	0.624	1.500	7.64	10.00	[0.2 - 2]
debtRatioTTM	0.0111	-1.500	9.82	-10.00	[0 - 0.6]
interestCoverageTTM	480.82	1.000	10.00	10.00	[3 - 30]
operatingCashFlowPerShareTTM	25.53	2.00	1.490	2.98	[0 - 30]
freeCashFlowPerShareTTM	25.53	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0.0187	-1.500	9.93	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.543	1.000	4.28	4.28	[0.2 - 0.8]
operatingProfitMarginTTM	0.287	1.000	6.27	6.27	[0.1 - 0.6]
cashFlowToDebtRatioTTM	3.09	1.000	10.00	10.00	[0.2 - 2]
assetTurnoverTTM	1.663	0.800	2.25	1.799	[0.5 - 2]
Total Score				11.10

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	32.94	1.000	6.77	0	[1 - 100]
returnOnEquityTTM	0.645	2.50	6.11	5.92	[0.1 - 1.5]
freeCashFlowPerShareTTM	25.53	2.00	1.490	10.00	[0 - 30]
dividendYielPercentageTTM	1.936	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	25.53	2.00	1.490	2.98	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-55.78	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0206	1.000	-1.984	0	[0.1 - 0.5]
Total Score				2.07

Sanofi India Limited

Sanofi India Limited manufactures and trades in drugs and pharmaceutical products in India, Singaporem and internationally. It provides pharmaceutical products in various therapeutic areas, such as diabetes, cardiology, thrombosis, central nervous system, anti-infective, epilepsy, allergy and vitamins, anti-histamines, and minerals and supplements under the Lantus, Toujeo, Clexane, Amaryl, Cardace, Targocid, Frisium, Combiflam, DePura, Allegra, and Avil brands through independent distributors. The company also exports its products. The company was formerly known as Aventis Pharma Limited and changed its name to Sanofi India Limited in May 2012. The company was incorporated in 1956 and is headquartered in Mumbai, India. Sanofi India Limited is a subsidiary of Hoechst GmbH.